Singapore Clinical Trial: A Phase III, Open-label, Randomised Study of Datopotamab Deruxtecan (Dato-DXd) With or Without Durvalumab Compared with Investigator’s Choice of Chemotherapy (Paclitaxel, Nab-paclitaxel or Gemcitabine + Carboplatin) in Combination With Pembrolizumab in Patients with PD-L1 Positive Locally Recurrent Inoperable or Metastatic Triple-negative Breast Cancer (TROPION-Breast05)

Singapore, May 9 -- The Health Sciences Authority received information related to the study titled 'A Phase III, Open-label, Randomised Study of Datopotamab Deruxtecan (Dato-DXd) With or Without Durva... Read More

Singapore Clinical Trial: TulmiSTAR-01: A two-part, Phase I dose escalation and expansion followed by a randomized, open-label multicenter, Phase II study to assess the safety and efficacy of the combination of tulmimetostat (DZR123) and JSB462 (luxdegalutamide) vs standard of care in patients with progressive metastatic castrate resistant prostate cancer

Singapore, May 9 -- The Health Sciences Authority received information related to the study titled 'TulmiSTAR-01: A two-part, Phase I dose escalation and expansion followed by a randomized, open-label... Read More

Singapore Clinical Trial: A Master Protocol of an Open-Label, Multi-Drug, Multi-Centre, Phase II Study to Evaluate the Safety, Tolerability, Pharmacokinetics, Immunogenicity, and Antitumour Activity of Novel Combinations in Participants with Locally Advanced or Metastatic Non-Small Cell Lung Cancer (LIBRA)

Singapore, May 9 -- The Health Sciences Authority received information related to the study titled 'A Master Protocol of an Open-Label, Multi-Drug, Multi-Centre, Phase II Study to Evaluate the Safety,... Read More

Singapore Clinical Trial: A Phase 2b, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Tulisokibart in Participants with Moderate to Severe Hidradenitis Suppurativa

Singapore, May 9 -- The Health Sciences Authority received information related to the study titled 'A Phase 2b, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety o... Read More

Singapore Clinical Trial: A Randomized Phase 2 Study of Casdozokitug in Combination With Toripalimab Plus Bevacizumab in Participants With Unresectable and/or Locally Advanced or Metastatic Hepatocellular Carcinoma

Singapore, May 9 -- The Health Sciences Authority received information related to the study titled 'A Randomized Phase 2 Study of Casdozokitug in Combination With Toripalimab Plus Bevacizumab in Parti... Read More

Singapore Clinical Trial: Prospective randomised controlled evaluation of Tetracycline ointment for preventing infections in uncomplicated soft-tissue wounds repaired in the emergency department – a pilot study.

Singapore, May 9 -- The Health Sciences Authority received information related to the study titled 'Prospective randomised controlled evaluation of Tetracycline ointment for preventing infections in u... Read More

గురు గోచారం 2026: జూన్ 2 నుంచి కర్కాటకంలోకి బృహస్పతి.. ఈ 4 రాశుల జాతకం మారబోతోంది!

భారతదేశం, మే 9 -- ఖగోళంలో అతి పెద్ద గ్రహం, శుభ గ్రహంగా పిలిచే బృహస్పతి (గురుడు) తన రాశిని మార్చుకోబోతున్నాడు. జ్యోతిష్య శాస్త్రం ప్రకారం శని తర్వాత అంతటి ప్రభావం చూపే గ్రహం గురుడు మాత్రమే. ప్రస్తుతం మ... Read More

Assam Career 2026 : Assam Cricket Association Recruitment

Guwahati, May 9 -- Applications are invited for recruitment of various coaching and technical positions or career in Assam Cricket Association in 2026. Assam Cricket Association is inviting applicati... Read More

Les Émirats arabes unis injectent 49 milliards $ pour accélérer l’essor de l’industrie locale

Chad, May 9 -- Les Émirats arabes unis vont localiser plus de 5 000 produits dans le cadre de leur stratégie de souveraineté industrielle, a annoncé le ministre de l’Industrie et des Technologies avan... Read More

Singapore Clinical Trial: Responses Against Paramyxoviruses in T cells with crOss Reactivity

Singapore, May 9 -- The Health Sciences Authority received information related to the study titled 'Responses Against Paramyxoviruses in T cells with crOss Reactivity'. The following are the other rel... Read More

• ««
• «
• 18872
• 18873
• 18874
• 18875
• 18876
• 18877
• 18878
• 18879
• 18880
• 18881
• »
• »»